Login / Signup

P2Y12 Inhibitor or Aspirin Monotherapy in Patients with Coronary Artery Disease: is it Time for a Paradigm Shift?

Felice GragnanoAntonio CapolongoPaolo Calabrò
Published in: Current vascular pharmacology (2023)
Keyphrases
  • low dose
  • combination therapy
  • cardiovascular events
  • antiplatelet therapy
  • open label
  • randomized controlled trial
  • anti inflammatory drugs
  • type diabetes
  • clinical trial
  • atrial fibrillation
  • study protocol